Literature DB >> 23725858

The autoimmune basis of narcolepsy.

Josh Mahlios1, Alberto K De la Herrán-Arita, Emmanuel Mignot.   

Abstract

Narcolepsy is a neurological disorder characterized by excessive daytime sleepiness, cataplexy, hypnagonic hallucinations, sleep paralysis, and disturbed nocturnal sleep patterns. Narcolepsy is caused by the loss of hypocretin (orexin)-producing neurons in the lateral hypothalamus. Evidence, such as a strong association with HLA DQB1*06:02, strongly suggests an autoimmune basis targeting hypocretin neurons. Genome-wide association studies have strengthened the association between narcolepsy and immune system gene polymorphisms, including the identification of polymorphisms in the T cell receptor alpha locus, TNFSF4 (also called OX40L), Cathepsin H (CTSH) the purinergic receptor P2RY11, and the DNA methyltransferase DNMT1. Recently, attention has been raised regarding a spike in cases of childhood narcolepsy in 2010 following the 2009 H1N1 pandemic (pH1N1) in China and vaccination with Pandemrix, an adjuvanted H1N1 vaccine that was used in Europe. How the immune system may be involved in disease initiation and/or progression remains a challenge to researchers. Potential immunological pathways that could lead to the specific elimination of hypocretin producing neurons include molecular mimicry or bystander activation, and are likely a combination of genetic and environmental factors, such as upper airway infections.
Copyright © 2013 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23725858      PMCID: PMC3848424          DOI: 10.1016/j.conb.2013.04.013

Source DB:  PubMed          Journal:  Curr Opin Neurobiol        ISSN: 0959-4388            Impact factor:   6.627


  56 in total

Review 1.  Hypocretins in the control of sleep and wakefulness.

Authors:  Patricia Bonnavion; Luis de Lecea
Journal:  Curr Neurol Neurosci Rep       Date:  2010-05       Impact factor: 5.081

2.  Translational profiling of hypocretin neurons identifies candidate molecules for sleep regulation.

Authors:  Jasbir Dalal; Jee Hoon Roh; Susan E Maloney; Afua Akuffo; Samir Shah; Han Yuan; Brie Wamsley; Wendell B Jones; Cristina de Guzman Strong; Paul A Gray; David M Holtzman; Nathaniel Heintz; Joseph D Dougherty
Journal:  Genes Dev       Date:  2013-02-21       Impact factor: 11.361

3.  Hypocretin (orexin) deficiency in human narcolepsy.

Authors:  S Nishino; B Ripley; S Overeem; G J Lammers; E Mignot
Journal:  Lancet       Date:  2000-01-01       Impact factor: 79.321

4.  HLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patients.

Authors:  E Mignot; R Hayduk; J Black; F C Grumet; C Guilleminault
Journal:  Sleep       Date:  1997-11       Impact factor: 5.849

5.  Genome-wide gene expression profiling of human narcolepsy.

Authors:  Camilla Bernardini; Wanda Lattanzi; Paolo Bosco; Christian Franceschini; Giuseppe Plazzi; Fabrizio Michetti; Raffaele Ferri
Journal:  Gene Expr       Date:  2012

6.  HLA-DQ-associated predisposition to and dominant HLA-DR-associated protection against rheumatoid arthritis.

Authors:  I E van der Horst-Bruinsma; H Visser; J M Hazes; F C Breedveld; W Verduyn; G M Schreuder; R R de Vries; E Zanelli
Journal:  Hum Immunol       Date:  1999-02       Impact factor: 2.850

7.  Medical exposures in youth and the frequency of narcolepsy with cataplexy: a population-based case-control study in genetically predisposed people.

Authors:  Thomas D Koepsell; William T Longstreth; Thanh G N Ton
Journal:  J Sleep Res       Date:  2009-08-31       Impact factor: 3.981

8.  AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland.

Authors:  Hanna Nohynek; Jukka Jokinen; Markku Partinen; Outi Vaarala; Turkka Kirjavainen; Jonas Sundman; Sari-Leena Himanen; Christer Hublin; Ilkka Julkunen; Päivi Olsén; Outi Saarenpää-Heikkilä; Terhi Kilpi
Journal:  PLoS One       Date:  2012-03-28       Impact factor: 3.240

9.  Common variants in P2RY11 are associated with narcolepsy.

Authors:  Birgitte R Kornum; Minae Kawashima; Juliette Faraco; Ling Lin; Thomas J Rico; Stephanie Hesselson; Robert C Axtell; Hedwich Kuipers; Karin Weiner; Alexandra Hamacher; Matthias U Kassack; Fang Han; Stine Knudsen; Jing Li; Xiaosong Dong; Juliane Winkelmann; Giuseppe Plazzi; Sona Nevsimalova; Seung-Chul Hong; Yutaka Honda; Makoto Honda; Birgit Högl; Thanh G N Ton; Jacques Montplaisir; Patrice Bourgin; David Kemlink; Yu-Shu Huang; Simon Warby; Mali Einen; Jasmin L Eshragh; Taku Miyagawa; Alex Desautels; Elisabeth Ruppert; Per Egil Hesla; Francesca Poli; Fabio Pizza; Birgit Frauscher; Jong-Hyun Jeong; Sung-Pil Lee; Kingman P Strohl; William T Longstreth; Mark Kvale; Marie Dobrovolna; Maurice M Ohayon; Gerald T Nepom; H-Erich Wichmann; Guy A Rouleau; Christian Gieger; Douglas F Levinson; Pablo V Gejman; Thomas Meitinger; Paul Peppard; Terry Young; Poul Jennum; Lawrence Steinman; Katsushi Tokunaga; Pui-Yan Kwok; Neil Risch; Joachim Hallmayer; Emmanuel Mignot
Journal:  Nat Genet       Date:  2010-12-19       Impact factor: 38.330

10.  ImmunoChip study implicates antigen presentation to T cells in narcolepsy.

Authors:  Juliette Faraco; Ling Lin; Birgitte Rahbek Kornum; Eimear E Kenny; Gosia Trynka; Mali Einen; Tom J Rico; Peter Lichtner; Yves Dauvilliers; Isabelle Arnulf; Michel Lecendreux; Sirous Javidi; Peter Geisler; Geert Mayer; Fabio Pizza; Francesca Poli; Giuseppe Plazzi; Sebastiaan Overeem; Gert Jan Lammers; David Kemlink; Karel Sonka; Sona Nevsimalova; Guy Rouleau; Alex Desautels; Jacques Montplaisir; Birgit Frauscher; Laura Ehrmann; Birgit Högl; Poul Jennum; Patrice Bourgin; Rosa Peraita-Adrados; Alex Iranzo; Claudio Bassetti; Wei-Min Chen; Patrick Concannon; Susan D Thompson; Vincent Damotte; Bertrand Fontaine; Maxime Breban; Christian Gieger; Norman Klopp; Panos Deloukas; Cisca Wijmenga; Joachim Hallmayer; Suna Onengut-Gumuscu; Stephen S Rich; Juliane Winkelmann; Emmanuel Mignot
Journal:  PLoS Genet       Date:  2013-02-14       Impact factor: 5.917

View more
  41 in total

1.  Mutations in the intellectual disability gene KDM5C reduce protein stability and demethylase activity.

Authors:  Emily Brookes; Benoit Laurent; Katrin Õunap; Renee Carroll; John B Moeschler; Michael Field; Charles E Schwartz; Jozef Gecz; Yang Shi
Journal:  Hum Mol Genet       Date:  2015-02-09       Impact factor: 6.150

2.  Anti-brain antibodies are associated with more severe cognitive and behavioral profiles in Italian children with Autism Spectrum Disorder.

Authors:  I S Piras; L Haapanen; V Napolioni; R Sacco; J Van de Water; A M Persico
Journal:  Brain Behav Immun       Date:  2014-01-03       Impact factor: 7.217

3.  How to fix a broken clock.

Authors:  Analyne M Schroeder; Christopher S Colwell
Journal:  Trends Pharmacol Sci       Date:  2013-10-10       Impact factor: 14.819

4.  Narcolepsy in African Americans.

Authors:  Makoto Kawai; Ruth O'Hara; Mali Einen; Ling Lin; Emmanuel Mignot
Journal:  Sleep       Date:  2015-11-01       Impact factor: 5.849

Review 5.  Motivational activation: a unifying hypothesis of orexin/hypocretin function.

Authors:  Stephen V Mahler; David E Moorman; Rachel J Smith; Morgan H James; Gary Aston-Jones
Journal:  Nat Neurosci       Date:  2014-09-25       Impact factor: 24.884

Review 6.  Central Disorders of Hypersomnolence: Focus on the Narcolepsies and Idiopathic Hypersomnia.

Authors:  Zeeshan Khan; Lynn Marie Trotti
Journal:  Chest       Date:  2015-07       Impact factor: 9.410

7.  Narcolepsy and COVID-19: sleeping on an opportunity?

Authors:  Fabian-Xosé Fernandez; Julie Flygare; Michael A Grandner
Journal:  J Clin Sleep Med       Date:  2020-08-15       Impact factor: 4.062

8.  Hypocretin neuron-specific transcriptome profiling identifies the sleep modulator Kcnh4a.

Authors:  Laura Yelin-Bekerman; Idan Elbaz; Alex Diber; Dvir Dahary; Liron Gibbs-Bar; Shahar Alon; Tali Lerer-Goldshtein; Lior Appelbaum
Journal:  Elife       Date:  2015-10-01       Impact factor: 8.140

Review 9.  The complementary roles of Phase 3 trials and post-licensure surveillance in the evaluation of new vaccines.

Authors:  Pier Luigi Lopalco; Frank DeStefano
Journal:  Vaccine       Date:  2014-11-04       Impact factor: 3.641

10.  Conditional ablation of orexin/hypocretin neurons: a new mouse model for the study of narcolepsy and orexin system function.

Authors:  Sawako Tabuchi; Tomomi Tsunematsu; Sarah W Black; Makoto Tominaga; Megumi Maruyama; Kazuyo Takagi; Yasuhiko Minokoshi; Takeshi Sakurai; Thomas S Kilduff; Akihiro Yamanaka
Journal:  J Neurosci       Date:  2014-05-07       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.